Insider buying often signals confidence in a company's future prospects, which can lead to increased investor interest and a potential rise in stock price. In this case, Director Wayne Rothbaum's purchase of 5 million shares could be seen as a strong vote of confidence in Iovance Biotherapeutics, potentially leading to a short-term increase in the company's stock price.